Zevra Therapeutics Inc. (ZVRA)
NASDAQ: ZVRA
· Real-Time Price · USD
8.81
-0.31 (-3.45%)
At close: Jun 17, 2025, 3:59 PM
8.80
-0.17%
After-hours: Jun 17, 2025, 04:20 PM EDT
-3.45% (1D)
| Bid | 8.22 |
| Market Cap | 482M |
| Revenue (ttm) | 40.59M |
| Net Income (ttm) | -91.99M |
| EPS (ttm) | -1.94 |
| PE Ratio (ttm) | -4.54 |
| Forward PE | 13.6 |
| Analyst | Strong Buy |
| Ask | 9.45 |
| Volume | 384,123 |
| Avg. Volume (20D) | 553,482 |
| Open | 9.04 |
| Previous Close | 9.13 |
| Day's Range | 8.81 - 9.21 |
| 52-Week Range | 4.20 - 9.76 |
| Beta | 1.99 |
About ZVRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZVRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZVRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+3.43%
Zevra Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+5.41%
Zevra Therapeutics shares are trading higher after the company announced it will sell its Pediatric Disease Priority Review Voucher for gross proceeds of $150 million.
